Improved GP care for sickle cell could cut hospital admissions

Improved treatment of patients with sickle cell disease in primary care could reduce hospital admission rates, researchers believe.

Sickle cell disease: researchers say uncomplicated sickle cell pain episodes may be more efficiently managed in a primary care setting (Photo: SPL)
Sickle cell disease: researchers say uncomplicated sickle cell pain episodes may be more efficiently managed in a primary care setting (Photo: SPL)

An Imperial College team analysed 1,090 emergency hospital admissions for sickle cell disease over 30 months in the London borough of Brent, an area of high prevalence for the disease.

The researchers found that 74% of all bed days for patients admitted with sickle cell disease were associated with those who had been admitted multiple times during the analysis period.

The researchers believe that long-term management of uncomplicated sickle cell pain episodes may be more efficiently managed in a primary care setting. They suggest that patients who are admitted multiple times over short periods may be good candidates for GP interventions.

Primary care interventions would reduce patients’ risk of SCD-related complications and be more cost effective for the NHS than hospital admissions, the researchers argue. Interventions that move management of sickle cell disease from tertiary towards primary care have been successfully implemented in Sheffield and elsewhere, they point out.

Previous research has also shown that a 40% reduction in sickle cell A&E attendance can be achieved by allowing sickle cell disease patients to bypass A&E and receive primary care treatment within hospital.

The researchers said they would now identify GP practices with the highest numbers of sickle cell disease patients who frequently seek emergency care. These practices will be earmarked for an education intervention designed to help further engage GPs in the care and management of patients with sickle cell disease.

The researchers concluded: ‘More appropriate management of sickle cell disease patients in the community may contribute to better health outcomes for patients, as well as economic benefits for the local health economy.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Summary of changes to the GP contract 2021/22

Summary of changes to the GP contract 2021/22

The BMA and NHS England have agreed minor changes to the GP contract for 2021/22....

Minor changes agreed to GP contract for 2021/22 amid ongoing pandemic pressure

Minor changes agreed to GP contract for 2021/22 amid ongoing pandemic pressure

Changes to the GP contract for 2021/22 will be 'minimal' under a deal struck between...

What's coming up at the RCGP 2021 online conference - Dr David R Williams confirmed

What's coming up at the RCGP 2021 online conference - Dr David R Williams confirmed

The RCGP two-day virtual event takes place next month with keynote speaker Dr David...

GPs back BMA to lead talks on future of primary care networks

GPs back BMA to lead talks on future of primary care networks

GPs have voted for the BMA to continue to represent the profession in talks with...

COVID-19 vaccine deliveries paused in some areas to tackle 'geographical inequality'

COVID-19 vaccine deliveries paused in some areas to tackle 'geographical inequality'

Some GP-led vaccination sites will miss out on COVID-19 vaccine deliveries next week...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...